Scientific evidence, not popular ideas, should drive probiotic and prebiotic recommendations in clinical settings. Globally, evidence is continually emerging on how probiotics and prebiotics can be effectively used in patient ...
May 15, 2023
0
9
In February 2023, the U.S. Centers for Disease Control and Prevention (CDC) warned people against using EzriCare eye drops because bottles of the product had been linked to drug-resistant bacterial infections causing vision ...
May 11, 2023
0
8
Overuse of antibiotic prescriptions for patients with upper respiratory illnesses at urgent care clinics in the United States has been an ongoing challenge, but a new study led by researchers at two Utah health systems—Intermountain ...
May 11, 2023
0
38
Arterial stiffness may be a novel risk factor for metabolic syndrome in teens, a new study concludes. The paper was published in the American Journal of Physiology–Heart and Circulatory Physiology. It was conducted in collaboration ...
Apr 24, 2023
0
2
New research presented at this week's European Congress of Clinical Microbiology & Infectious Diseases (Copenhagen, April 15-18) shows how interventions focused on so-called "supercontactors" in hospitals and other long term ...
Apr 17, 2023
0
3
A genetic study analyzing the microbiome (bacteria in the gut) of a large nationally representative sample of the Finnish population finds that geographic, demographic, diet, and lifestyle factors are driving the spread of ...
Apr 14, 2023
0
2
A multidisciplinary group of tuberculosis experts from the TBnet and RESIST-TB networks have reached a consensus on key issues related to the molecular prediction of Mycobacterium tuberculosis antibiotic sensitivity or resistance ...
Apr 14, 2023
0
9
In adolescents, sedentary time may increase heart size three times more than moderate-to-vigorous physical activity, a paper published in the Scandinavian Journal of Medicine & Science in Sports concludes. The study was conducted ...
Apr 12, 2023
0
3
A new antimalarial drug candidate, discovered through a longstanding collaboration between WEHI and global biopharmaceutical company MSD has entered Phase 1 clinical testing in healthy participants. The candidate drug inhibits ...
Apr 6, 2023
0
2
A rare strain of a drug-resistant bacteria found in some recalled eye drops has been linked to dozens of infections across the United States.
Apr 4, 2023
0
12
